Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile

被引:47
作者
Carmona-Fernandes, Diana [1 ]
Santos, Maria Jose [1 ,2 ]
Canhao, Helena [1 ,3 ]
Fonseca, Joao Eurico [1 ,3 ]
机构
[1] Lisbon Acad Med Ctr, Inst Mol Med, Rheumatol Res Unit, P-1649028 Lisbon, Portugal
[2] Hosp Garcia de Orta, Dept Rheumatol, P-2801951 Pragal, Almada, Portugal
[3] Hosp Santa Maria, Rheumatol & Bone Metab Dis Dept, P-1649035 Lisbon, Portugal
关键词
Anti-Rib-P; Systemic lupus erythematosus; Antibodies; CONNECTIVE-TISSUE DISEASES; C-REACTIVE PROTEIN; ANTIBODIES; ASSOCIATION; CRITERIA; CLASSIFICATION; VALIDATION; NEPHRITIS; ELISA; INDEX;
D O I
10.1186/1741-7015-11-98
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study was devised to assess the performance of anti-ribosomal P (anti-Rib-P) antibodies in the diagnosis of systemic lupus erythematosus (SLE) and the association of these antibodies with the clinical features of SLE. Methods: We used a fluorescence enzyme immunoassay to determine anti-Rib-P levels in an SLE group, a rheumatic disease control (RDC) group (rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis and juvenile idiopathic arthritis), and a healthy control (HC) group. We also determined anti-Smith antigen (anti-Sm) and anti-double-stranded DNA (anti-dsDNA) antibody levels. Receiver operating characteristic (ROC) curves were constructed and the best cut-off points for positivity were determined. Using regression analysis, the relationship between clinical variables and autoantibody levels was analyzed. Results: In total, 127 patients with SLE, 256 controls with other rheumatic diseases, and 100 HCs were studied. Anti-Rib-P autoantibodies were positive in 18 (14.2%) of the patients with SLE (mean concentration of 30.6 +/- 46.9 U/ml) and in 2 patients with RA (0.8% of the RDC group). In addition, 12 patients with SLE (9.4%) were positive for anti-Sm (31.1 +/- 40.8 U/ml) and 63 (49.6%) were positive for anti-dsDNA autoantibodies (88.4 +/- 88.5 U/ml). When we assessed the 18 patients with SLE who had tested positive for anti-Rib-P, we found that 4 of these were positive for anti-Rib-P only, whereas 12 were positive for anti-Rib-P plus anti-dsDNA, and 2 were positive for all three antibodies. There were no samples positive for anti-Rib-P plus anti-Sm. The specificity, sensitivity, positive likelihood ratio, and negative likelihood ratio of anti-Rib-P for SLE diagnosis were 99.4%, 14.2%, 23.7%, and 0.86%, respectively. Caucasian ethnicity was associated with lower anti-Rib-P antibody levels. No relation was found between anti-Rib-P levels and neuropsychiatric or other clinical features. Conclusions: Anti-Rib-P autoantibodies have high specificity for SLE, and measurement of these might improve the accuracy of SLE diagnosis. In this study, we found that Caucasian ethnicity was associated with lower anti-Rib-P antibody levels.
引用
收藏
页数:8
相关论文
共 37 条
[21]   Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides [J].
Heinlen, Latisha D. ;
Ritterhouse, Lauren L. ;
McClain, Micah T. ;
Keith, Michael P. ;
Neas, Barbara R. ;
Harley, John B. ;
James, Judith A. .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (07) :719-727
[22]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[23]   Anti-nuscleosome antibody, a reliable indicator for lupus nephritis [J].
Kiss, Emese ;
Lakos, Gabriella ;
Szegedi, Gyula ;
Poor, Gyula ;
Szodoray, Peter .
AUTOIMMUNITY, 2009, 42 (05) :393-398
[24]   Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus [J].
Lin, JLJ ;
Dubljevic, V ;
Fritzler, MJ ;
Toh, BH .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 141 (01) :155-164
[25]   International multicenter evaluation of autoantibodies to ribosomal P proteins [J].
Mahler, M ;
Kessenbrock, K ;
Szmyrka, M ;
Takasaki, Y ;
Garcia-De La Torre, I ;
Shoenfeld, Y ;
Hiepe, F ;
Shun-le, C ;
von Mühlen, CA ;
Locht, H ;
Höpfl, P ;
Wiik, A ;
Reeves, W ;
Fritzler, MJ .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (01) :77-83
[26]   Technical and clinical evaluation of anti-ribosomal P protein immunoassays [J].
Mahler, M ;
Kessenbrock, K ;
Raats, J ;
Fritzler, MJ .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2004, 18 (04) :215-223
[27]   Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies [J].
Mahler, Michael ;
Ngo, Jennifer T. ;
Schulte-Pelkum, Johannes ;
Luettich, Tanja ;
Fritzler, Marvin J. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (06)
[28]   BASIC PRINCIPLES OF ROC ANALYSIS [J].
METZ, CE .
SEMINARS IN NUCLEAR MEDICINE, 1978, 8 (04) :283-298
[29]   The ACR nomenclature for CNS lupus revisited [J].
Nived, O ;
Sturfelt, G ;
Liang, MH ;
De Pablo, P .
LUPUS, 2003, 12 (12) :872-876
[30]   Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies [J].
Olesinska, Marzena ;
Chwalinska-Sadowska, Hanna ;
Wiesik-Szewczyk, Ewa ;
Mielnik, Pawel ;
Zabek, Jakub .
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (03) :76-80